Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of SF3B as target in preparation of drugs for preventing or treating breast cancer

A technology of SF3B1 and breast cancer, applied in the field of biomedicine, can solve problems such as unclear SF3B1 breast cancer

Pending Publication Date: 2020-01-31
SHANXI MEDICAL UNIV
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It remains unclear whether SF3B1 may be a molecular target in breast cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of SF3B as target in preparation of drugs for preventing or treating breast cancer
  • Application of SF3B as target in preparation of drugs for preventing or treating breast cancer
  • Application of SF3B as target in preparation of drugs for preventing or treating breast cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0025] According to the guidelines of the local ethics committee, cancer tissue samples from 110 patients diagnosed with breast cancer were obtained from the First Affiliated Hospital of Shanxi Medical University, 40 of which had matching non-tumor control tissues. Molecular subtypes include Luminal A (38), Luminal B (38), HER2-enriched (14) and triple-negative / basal-like breast cancer (20). None of the patients received radiation or chemotherapy before surgery.

[0026] Immunohistochemistry: Paraffin-embedded formalin-fixed tissue samples were used for immunohistochemistry. Cut the specimen into 4 μm thick slices. Sections were deparaffinized and rehydrated using graded xylene and ethanol. Then the sample was washed with 3% H 2 o 2 Incubate for 10-15 min and rinse three times with distilled water. After antigen extraction in sodium citrate buffer (pH 6.0) for 2 min and blocking in goat serum, sections were incubated with specific anti-SF3B1 antibody (Abcam) diluted 1:200...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of biological medicine, and provides a novel molecular target SF3B1 for preventing or treating breast cancer and application of the target in the parathionof drugs for preventing or treating breast cancer. The SF3B1 gene is used as a target, and the expression of the SF3B1 gene is reduced by adopting gene knockout, gene knockdown or chemical drugs. Theexpression of SF3B1 in breast cancer cells was significantly improved compared with that in normal tissue cells. SF3B1 expression level is correlated with lymph node metastasis. SF3B1 knockout in breast cancer can induce apoptosis and cell cycle arrest. SF3B1 knockout can reduce cell proliferation, colony formation, invasion and migration ability. Exon skipping is the most common splicing event after SF3B1 knockout. Researches show that SF3B1 may be an important molecular target for the treatment of breast cancer.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and specifically relates to the application of SF3B1 as a target in the preparation of drugs for preventing or treating breast cancer. Background technique [0002] Aberrant splicing is one of the hallmarks of cancer-associated phenotypes, and tumorigenesis is often accompanied by aberrant RNA splicing. It is well known that alternative splicing (AS) is an important feature of eukaryotes, controlled by the spliceosome composed of small nuclear RNA (snRNA) and various proteins. Mutations and changes in expression levels of splicing factor genes can lead to exon loss, intron retention, misidentification of splice sites, and changes in open reading frames, thereby affecting most of the cells involved in cell cycle control, angiogenesis, apoptosis, Post-transcriptional processing and expression of metastatic genes. Cancers have many alternative splicing events that are absent in normal samples....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6886
CPCC12Q1/6886C12Q2600/158
Inventor 张玲刘峰刘静程彩霞毕炀辉张燕燕宋彬张海涛卞琳高迎真
Owner SHANXI MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com